Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2023-10-29 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "西藏易明西雅医药科技股份有限公司2023 年第三季度报告" which translates to "Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. 2023 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2023. The document includes comprehensive financial figures, explanations of changes in financial indicators, shareholder information, and other important matters such as litigation and investment activities. The presence of detailed quarterly financial statements and analysis confirms this is a comprehensive interim financial report for a period shorter than a full fiscal year. It is not an announcement or a brief summary but a full report with substantive financial data and analysis. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-29 Chinese
2023-065 回购报告书
Transaction in Own Shares Classification · 100% confidence The document is a detailed announcement regarding the company's plan to repurchase its own shares using its own funds, specifying the purpose (for equity incentive plans), the amount, price range, implementation period, and related risks. It includes information about the board's authorization, independent directors' opinions, and regulatory compliance. The content focuses on the share repurchase plan and its implications rather than financial results or earnings. The document length is 7,839 characters, which is substantial and contains detailed information about the repurchase plan itself, not just an announcement of a report. Therefore, this document fits the category of a Transaction in Own Shares (POS) filing, which covers share buybacks or repurchases by the company.
2023-10-29 Chinese
关于使用自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of the company's use of its own funds for cash management, specifically investing in financial products. It details the amounts invested, risk assessments, and compliance with regulatory requirements. The document does not contain financial statements or comprehensive financial data but rather updates on financing activities and investment decisions. It is not a full financial report, earnings release, or audit report. The content fits best under Capital/Financing Update (CAP) as it provides updates on the company's financing activities and capital management.
2023-10-12 Chinese
关于高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel, specifically the vice general manager and chairman of a subsidiary. It details the resignation, the reasons, and the continuation of other roles by the individual. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content fits the category of Board/Management Information, which covers announcements of changes in senior management.
2023-10-10 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company 西藏易明西雅医药科技股份有限公司 (stock code 002826). It explains the situation of the stock price rising abnormally over three consecutive trading days, confirms that there is no undisclosed material information affecting the stock price, and reassures investors about the company's normal operations and compliance with disclosure rules. There are no financial statements, earnings data, or detailed financial analysis present. The document is a regulatory announcement about stock trading behavior and compliance, not a financial report or management discussion. It fits the category of a Regulatory Filing (RNS) as it is a compliance-related disclosure that does not fit other specific categories.
2023-09-19 Chinese
第三届监事会第十三次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company regarding approval of credit applications and guarantees. It includes details about the meeting, voting results, and references to other announcements for more information. The document is short (850 characters) and does not contain financial statements or detailed financial data. It is an official announcement of board/committee decisions rather than a full report or financial filing. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management.
2023-09-07 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.